Procter & Gamble Form 4: R&D chief gets new equity awards, no sales
Rhea-AI Filing Summary
Form 4 highlights (filed 7 Aug 2025): Procter & Gamble’s Chief Research, Development & Innovation Officer, Moses V. J. Aguilar, disclosed routine equity accruals delivered through company compensation plans—no open-market trading occurred.
- New awards: 780 Restricted Stock Units (RSUs) granted on 08/07/2025; 12.5783 dividend-equivalent RSUs credited 05/15/2025; 0.6323 shares of Series A preferred stock credited 07/14/2025 via retirement plan.
- Cost: All issuances at $0, classified as code “A” (award) with “V” modifier, indicating non-discretionary, benefit-plan transactions.
- Post-transaction holdings: Direct ownership—25,351.0828 common shares plus 877.6365 RSUs; Indirect—6,750.7456 common shares and 1,782.2509 preferred shares held by plan trustees.
- RSUs and preferred shares convert to PG common stock upon retirement or plan distribution per plan rules.
No sales, dispositions, or market purchases were reported; the filing does not materially alter insider ownership percentage or signal a directional view on PG’s share price.
Positive
- None.
Negative
- None.
Insights
TL;DR — Routine plan-based awards; neutral for valuation.
The transactions are automatic grants tied to dividend reinvestment and retirement benefits, representing <0.001% of PG’s float. There is no cash outlay by the insider and no open-market activity, so they neither indicate bullish conviction nor raise governance concerns. Such filings are common for senior executives at large-cap issuers and carry de minimis market impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 780 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| Grant/Award | Series A Preferred Stock | 0.632 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 12.578 | $0.00 | -- |
Footnotes (1)
- Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan. Reflects adjustment to PST through July 14, 2025. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock. Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.
